skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Synthesis, radiolabeling, and biological evaluation of (R)- and (S)-2-amino-5-[18F]fluoro-2-methylpentanoic acid ((R)-, (S)-[18F]FAMPe) as potential positron emission tomography tracers for brain tumors

Journal Article · · Journal of Medicinal Chemistry
DOI:https://doi.org/10.1021/jm502023y· OSTI ID:1346033

In this paper, a novel 18F-labeled α,α-disubstituted amino acid-based tracer, 2-amino-5-[18F]fluoro-2-methylpentanoic acid ([18F]FAMPe), has been developed for brain tumor imaging with a longer alkyl side chain than previously reported compounds to increase brain availability via system L amino acid transport. Both enantiomers of [18F]FAMPe were obtained in good radiochemical yield (24–52% n = 8) and high radiochemical purity (>99%). In vitro uptake assays in mouse DBT gliomas cells revealed that (S)-[18F]FAMPe enters cells partly via sodium-independent system L transporters and also via other nonsystem A transport systems including transporters that recognize glutamine. Biodistribution and small animal PET/CT studies in the mouse DBT model of glioblastoma showed that both (R)- and (S)-[18F]FAMPe have good tumor imaging properties with the (S)-enantiomer providing higher tumor uptake and tumor to brain ratios. Finally, comparison of the SUVs showed that (S)-[18F]FAMPe had higher tumor to brain ratios compared to (S)-[18F]FET, a well-established system L substrate.

Research Organization:
Washington Univ., St. Louis, MO (United States). School of Medicine
Sponsoring Organization:
USDOE Office of Science (SC)
Grant/Contract Number:
SC0004832
OSTI ID:
1346033
Journal Information:
Journal of Medicinal Chemistry, Vol. 58, Issue 9; ISSN 0022-2623
Publisher:
American Chemical Society (ACS)Copyright Statement
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 11 works
Citation information provided by
Web of Science

References (42)

Radiohalogenated nonnatural amino acids as PET and SPECT tumor imaging agents: RADIOHALOGENATED NONNATURAL AMINO ACIDS journal July 2011
18 F-AFETP, 18 F-FET, and 18 F-FDG Imaging of Mouse DBT Gliomas journal May 2013
Non-natural amino acids for tumor imaging using positron emission tomography and single photon emission computed tomography journal July 2008
Fluorine-18 Labeled Amino Acids for Oncologic Imaging with Positron Emission Tomography journal May 2013
Comparison of 18F-FET and 18F-FDG PET in brain tumors journal October 2009
FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading journal September 2007
Prognostic Value of O-(2-18F-Fluoroethyl)-L-Tyrosine PET and MRI in Low-Grade Glioma journal April 2007
O-(2-[18F]fluoroethyl)-l-tyrosine: uptake mechanisms and clinical applications journal April 2006
O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours journal January 2005
Comparative Evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for Metabolic Imaging of Low Grade Gliomas journal January 2009
3,4-Dihydroxy-6-[18F]-Fluoro-L-Phenylalanine Positron Emission Tomography in Patients With Central Motor Disorders and in Evaluation of Brain and Other Tumors journal November 2007
Detection of Recurrent Prostate Carcinoma with anti -1-Amino-3- 18 F-Fluorocyclobutane-1-Carboxylic Acid PET/CT and 111 In–Capromab Pendetide SPECT/CT journal June 2011
6-l- 18 F-Fluorodihydroxyphenylalanine PET in Neuroendocrine Tumors: Basic Aspects and Emerging Clinical Applications journal March 2008
Comparative evaluation of transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid and l-[methyl-11C]methionine in human glioma cell lines journal October 2013
Differences in Transport Mechanisms of trans-1-Amino-3-[18F]Fluorocyclobutanecarboxylic Acid in Inflammation, Prostate Cancer, and Glioma Cells: Comparison with l-[Methyl-11C]Methionine and 2-Deoxy-2-[18F]Fluoro-d-Glucose journal October 2013
Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo journal February 2015
Synthesis of Optically Pure 4-Fluoro-Glutamines as Potential Metabolic Imaging Agents for Tumors journal February 2011
PET Imaging of Glutaminolysis in Tumors by 18 F-( 2S,4R )4-Fluoroglutamine journal November 2011
Synthesis and evaluation of 18F labeled alanine derivatives as potential tumor imaging agents journal October 2012
(4 S )-4-(3- 18 F-Fluoropropyl)-l-Glutamate for Imaging of x C ¯ Transporter Activity in Hepatocellular Carcinoma Using PET: Preclinical and Exploratory Clinical Studies journal December 2012
Exploratory Clinical Trial of (4 S )-4-(3-[ 18 F]fluoropropyl)-l-glutamate for Imaging x C Transporter Using Positron Emission Tomography in Patients with Non–Small Cell Lung or Breast Cancer journal August 2012
Specific PET Imaging of x C Transporter Activity Using a 18 F-Labeled Glutamate Derivative Reveals a Dominant Pathway in Tumor Metabolism journal July 2011
Click Synthesis and Biologic Evaluation of ( R )- and ( S )-2-Amino-3-[1-(2-[ 18 F]Fluoroethyl)-1 H -[1,2,3]Triazol-4-yl]Propanoic Acid for Brain Tumor Imaging with Positron Emission Tomography journal November 2010
Imaging Tumour ATB0,+ Transport Activity by PET with the Cationic Amino Acid O-2((2-[18F]fluoroethyl)methyl-amino)ethyltyrosine journal December 2013
Synthesis, Radiolabeling, and Biological Evaluation of ( R )- and ( S )-2-Amino-3-[ 18 F]Fluoro-2-Methylpropanoic Acid (FAMP) and ( R )- and ( S )-3-[ 18 F]Fluoro-2-Methyl-2- N -(Methylamino)propanoic Acid ( N MeFAMP) as Potential PET Radioligands for Imaging Brain Tumors journal December 2009
Synthesis and evaluation of 2-amino-4-[18F]fluoro-2-methylbutanoic acid (FAMB): relationship of amino acid transport to tumor imaging properties of branched fluorinated amino acids journal May 2003
Radiolabeled Amino Acids for Tumor Imaging with PET:  Radiosynthesis and Biological Evaluation of 2-Amino-3-[ 18 F]fluoro-2-methylpropanoic Acid and 3-[ 18 F]Fluoro-2-methyl-2-(methylamino)propanoic Acid journal May 2002
In vivo Imaging in a Murine Model of Glioblastoma journal February 2007
Synthesis of (2S,4S)- and (2S,4R)-5-fluoroleucine and (2S,4S)-[5,5-2H2]-5-fluoroleucine journal January 2004
Facile Nucleophilic Fluorination Reactions Using tert -Alcohols as a Reaction Medium:  Significantly Enhanced Reactivity of Alkali Metal Fluorides and Improved Selectivity journal February 2008
System a amino acid transport-targeted brain and systemic tumor PET imaging agents 2-amino-3-[18F]fluoro-2-methylpropanoic acid and 3-[18F]fluoro-2-methyl-2-(methylamino)propanoic acid journal January 2015
Comparative Evaluation of 18F-Labeled Glutamic Acid and Glutamine as Tumor Metabolic Imaging Agents journal August 2012
Amino acid sensing and mTOR regulation: inside or out? journal January 2009
Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability journal June 2003
ASCT2 silencing regulates mammalian target-of-rapamycin growth and survival signaling in human hepatoma cells journal July 2007
Amino acid transporters ASCT2 and LAT1 in cancer: Partners in crime? journal August 2005
Ceramide down‐regulates System A amino acid transport and protein synthesis in rat skeletal muscle cells journal December 2004
Synthesis of new dimeric-PEG-supported cinchona ammonium salts as chiral phase transfer catalysts for the alkylation of Schiff bases with water as the solvent journal January 2007
Enantioselective syntheses of 2-amino-4-fluoropent-4-enoic acids. Isosteres of asparagine journal August 1999
Crotonase Catalysis Enables Flexible Production of Functionalized Prolines and Carbapenams journal December 2011
Stereoselective Iodocyclization of ( S )-Allylalanine Derivatives:  γ-Lactone vs Cyclic Carbamate Formation journal June 2007
New approach for the synthesis of [18F]fluoroethyltyrosine for cancer imaging: Simple, fast, and high yielding automated synthesis journal November 2009

Cited By (2)